Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIOP) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Fortress Biotech (FBIOP) over the last 13 years, with Q3 2025 value amounting to $8.8 million.

  • Fortress Biotech's Income towards Parent Company rose 13302.9% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.2 million, marking a year-over-year increase of 3667.35%. This contributed to the annual value of -$120.9 million for FY2024, which is 2160.11% up from last year.
  • As of Q3 2025, Fortress Biotech's Income towards Parent Company stood at $8.8 million, which was up 13302.9% from -$35.9 million recorded in Q2 2025.
  • Fortress Biotech's Income towards Parent Company's 5-year high stood at $8.8 million during Q3 2025, with a 5-year trough of -$62.4 million in Q4 2021.
  • Moreover, its 5-year median value for Income towards Parent Company was -$35.9 million (2025), whereas its average is -$37.1 million.
  • Its Income towards Parent Company has fluctuated over the past 5 years, first plummeted by 15968.02% in 2021, then skyrocketed by 13302.9% in 2025.
  • Fortress Biotech's Income towards Parent Company (Quarter) stood at -$62.4 million in 2021, then increased by 7.88% to -$57.4 million in 2022, then skyrocketed by 49.54% to -$29.0 million in 2023, then grew by 9.21% to -$26.3 million in 2024, then soared by 133.54% to $8.8 million in 2025.
  • Its last three reported values are $8.8 million in Q3 2025, -$35.9 million for Q2 2025, and -$21.8 million during Q1 2025.